HeartBeam, Inc.: director de Urioste George received 187,500 shares

What happened

• The filing reports that de Urioste George, a director, was granted two awards of 93,750 restricted stock units (RSUs) each on Oct 2, 2026, for a total of 187,500 RSUs. Each grant is reported as an award/acquisition (code A) at a price of $0.00 (derivative security).

Key details

• Transaction date and price: Oct 2, 2026; price $0.00; transaction code A (award/grant).
• Filing date and report period: filed Oct 9, 2026; period of report Oct 2, 2026.
• Shares owned after the transaction: not disclosed in the filing.
• Relevant footnotes from the filing:
  • F1: Each RSU represents a contingent right to receive one share upon settlement.
  • F2: RSUs were granted under the 2022 Equity Incentive Plan as an annual RSU award to non-employee directors; 100% of the RSUs vest on the earlier of Oct 2, 2027 or the date of the issuer's next annual meeting of stockholders, subject to continued service; vested RSUs will be settled in shares and RSUs do not expire.
  • F3: the filing also describes a stock option grant on Oct 2, 2026 with partial initial vesting and subsequent vesting and change-in-control acceleration.

Why it may matter

• These entries are awards of RSUs and are not market trades of existing shares.
• A filing does not show why the insider traded or why the company acted.